We are seeking to recruit a postdoctoral researcher for approximately 2 years in the first instance as part of the UCL medicinal chemistry core of the $63M READDI-AViDD consortium funded by the NIH to develop novel, direct-acting antivirals in advance of the next pandemic.
The post-holder will manage protein expression, purification and assay development, including interactions with other parts of READDI-AViDD protein team mostly in the US and Canada. The research will be carried out according to the open science principles of the Structural Genomics Consortium. This opening represents a rare and exciting opportunity to make a major international contribution to pandemic preparedness through basic research.
You must have an outstanding track record in the expression and purification of proteins as well as the establishment of binding assays with those proteins. You should have experience in the expression of proteins (ideally in a range of expression systems such as bacterial, mammalian and insect cells) and their purification, and the use of those proteins in establishing suitable binding assays (ideally SPR, NMR or thermal shift).
We will consider applications to work on a part-time, flexible and job share basis wherever possible.
If you have any queries regarding the vacancy please contact Professor Mat Todd (firstname.lastname@example.org). For enquiries regarding the application process, please contact the Staffing and HR Office (email@example.com).
Please note that the deadline for applications is the 31st July 2023